Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

Authors not listed

Center for Eye Research Australia · 2017

Abstract

Clinical trial investigating the role of hyperspectral imaging in the management of patients undergoing standard clinical treatment for naive neovascular choroidal membranes in age-related macular degeneration.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-12 MST

Cite this

APA
Anonymous. (2017). Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging. <em>Center for Eye Research Australia</em>. https://clinicaltrials.gov/study/NCT03105609
Vancouver
Anonymous. Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging. Center for Eye Research Australia. 2017.
BibTeX
@misc{anon2017Enhanc, title = {Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging}, author = {Anonymous}, journal = {Center for Eye Research Australia}, year = {2017}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings